Illumina Inc said on Monday it would buy cancer screening startup Grail Inc in a cash-and-stock deal worth $8 billion, buying out investors including Jeff Bezos and snatching back a business it hived off four years ago as a separate company.
Illumina is Grail’s largest shareholder, holding a 14.5% stake, and the deal is almost a month after the startup filed for a stock market listing.
Grail stockholders, including Illumina, will receive $3.5 billion in cash and $4.5 billion in shares of Illumina stock, the companies saidGrail plans to follow Galleri with more blood tests for cancer diagnosis, detection and post-treatment monitoring of cancer patients. Most liquid biopsies use next-generation sequencing to scan blood samples for fragments of tumor DNA in people previously diagnosed with cancer.
Analysts peg the market for liquid biopsies in the range of least $30 billion to $130 billion in the United States alone.“We don’t see the clear fit for acquiring a company that is still at a stage where clinical studies and clinical product development are still critical and will be for years,” Cowen analyst Doug Schenkel said in a client note.
Acquiring Grail would also create conflicts with many of Illumina’s existing clinical customers, Schenkel added, noting that many of Illumina’s major customers have ambitions to develop liquid biopsy based cancer screening tools.Reporting by Manojna Maddipatla in Bengaluru; Editing by Saumyadeb Chakrabarty and Bernard Orr
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Illumina to pay $8 billion for Jeff Bezos-backed cancer testing firm GrailGene sequencing company Illumina Inc will pay $8 billion in cash and stock to buy cancer screening startup Grail Inc, the companies said on Monday.
Weiterlesen »
Ex-GOP Arizona Senator Jeff Flake says next president should fill SCOTUS vacancy'Preserving the institution of the Senate should be paramount to any political gain,' Flake tweeted.
Weiterlesen »
Illumina to pay $8 billion for Jeff Bezos-backed cancer testing firm GrailGene sequencing company Illumina Inc will pay $8 billion in cash and stock to buy cancer screening startup Grail Inc, the companies said on Monday.
Weiterlesen »
French telecoms group Iliad plans to buy Poland's Play in $4.15 billion dealIliad plans to acquire Polish mobile phone operator Play in a 3.5 billion euros ($4.15 billion) deal, the French telecoms group said on Monday, adding that it has secured a deal to buy 40% of the firm's capital from key shareholders.
Weiterlesen »
The West Coast's wildfire real estate crisis has $8 billion at stake - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »
The West Coast's wildfire real estate crisis has $8 billion at stake - Business InsiderThe West Coast's record wildfire season has ground the real-estate industry to a halt with $8 billion of assets in danger — and it could be creating a new class of 'firebird' residents who move away seasonally
Weiterlesen »